Biotech startup exits stealth mode with $47M funding boost

02/14/2013 | Xconomy

Jounce Therapeutics has emerged from its quiet period with $47 million in initial funding. The biotech startup from Third Rock Ventures seeks to develop injectable protein drugs including antibodies as therapies for cancer.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN